The Action of Nine Chelators on Iron-Dependent Radical Damage

References

• Schnebli H. P., Hassan I. I., Hamilton K. O., Lynch S., Jin Y., Nick H. P., Peter H. H., Junker U., Walker, Ziel R., Khanna S. C., Dean R. T., Bergeron R. J. Towards better Chelation Therapy: Current Concepts and Research Strategy, R. J. Bergeron, 1993, Bergeron ed.
   Google Scholar
• Hershko C. Iron Chelators in Medicine. Molecular Aspects of Medicine 1992; 13(2)113–65
   PubMedGoogle Scholar
• Sephton-Smith R. Iron excretion in thalassemia major after administration of chelating agents. British Medical Journal 1962; ii: 1577
   Google Scholar
• Halliwell, Gutteridge J. M.C. Free Radicals in Biology and Medicine. Clarendon Press, Oxford 1989
   Google Scholar
• Goodwin J. F., Whitten C. F. Chelation of Ferrous sulphate solutions by Desferoxamine B. Nature 1965; 205: 281–283
   PubMed Web of Science ®Google Scholar
• Modell B., Berdoukas V. The clinical approach to thalassaemia. Grune and Stratton, London 1984
   Google Scholar
• Hider R. C., Hall A. D. Clinically useful chelators of tripositive elements. Progress in Medicinal Chemistry 1993; 28: 41–173
   Google Scholar
• Wilkins R. G.R.G. Kinetics and Mechanism of Reactions of Transition Metal Complexes. VCH, Weinheim 1992
   Google Scholar
• Miller D. M., Buettner G. R., Aust S. D. Transition metals as catalysts of “autoxidation” reactions 1990; 8: 95–108
   Google Scholar
• Grady R. W., Hershko C. HBED, a potent oral iron chelator. Annals of the New York Academy of Science 1990; 612: 361–8
   PubMed Web of Science ®Google Scholar
• Streater M., Taylor P. D., Hider R. C., Porter J. Novel 3-hydroxy-2(1h)-pyridinones. Synthesis, iron(III)-chelating properties, and biological activity. Journal of Medicinal Chemistry 1990; 33: 1749–1755
   PubMed Web of Science ®Google Scholar
• Bergeron R. J., Streiff R. R., Wiegand J., Luchetta G., Creary E. A., Peter H. H. A comparison of the iron clearing properties of 1,2,dimethyl-3-hydroxypyrid-4-one, 1,2,diethyl-3-hydroxypyrid-4-one and desferoxamine. Blood 1992; 79: 1882–90
   PubMed Web of Science ®Google Scholar
• Gutteridge J. M.C. “Iron and oxygen radicals in brain.”. Annals of Neurology 1992; 32: S16–S21
   Google Scholar
• Kozlov A. V., Yegorov D. Y., Vladimirov Y. A., Azizova O. A. Intracellular free iron in liver tissue and liver homogenate: studies with electron paramagnetic resonance on the formation of paramagnetic complexes with desferal and nitric oxide. Free Radical Biology and Medicine 1992; 13: 9–16
   PubMedGoogle Scholar
• Bralet J., Schreiber L., Bouvier C. Effect of acidosis and anoxia on iron delocalisation from brain homogenates. Biochemical Pharmacology 1992; 43: 979–983
   PubMed Web of Science ®Google Scholar
• Gutteridge J. M.C. Superoxide-dependent formation of hydroxyl radicals from ferric complexes and hydrogen peroxide: an evaluation of fourteen iron chelators. Free Radical Research Communications 1990; 9: 119–125
   PubMed Web of Science ®Google Scholar
• Simpson J. A., Cheeseman K. H., Smith S. E., Dean R. T. Free radical generation by copper and hydrogen peroxide: Stimulation by Hepes buffer. Biochemical Journal 1988; 254: 519–523
   PubMed Web of Science ®Google Scholar
• Buettner G. R. In the absence of catalytic metals ascorbate does not autoxidize at pH 7: ascor-bate as a test for catalytic metals. Journal of Biochemical and Biophysical Methods 1987; 16: 27–40
   Google Scholar
• Simpson J. A., Dean R. T. Stimulatory and inhibitory actions of proteins and amino acids on copper-catalysed free radical generation in the bulk phase. Free Radical Research Communications 1990; 10: 303–312
   PubMed Web of Science ®Google Scholar
• Hunt J. V., Simpson J. A., Dean R. T. Hydroperoxide-mediated fragmentation of proteins. Biochemical Journal 1988; 250: 87–93
   PubMed Web of Science ®Google Scholar
• Dean R. T., Nick H. P., Schnebli H. P. Free radicals inactivate human neutrophil elastase and its inhibitors with comparable efficiency. Biochemical and Biophysical Research Communications 1989; 159: 821–827
   PubMedGoogle Scholar
• Niki E. Free radical initiators as sources of water- or lipid-soluble peroxyl radicals. Methods in Enzymology 1990; 186: 100–8
   PubMed Web of Science ®Google Scholar
• Dean R. T., Hunt J. V., Grant A. J., Yamamoto Y., Niki E. Free radical damage to proteins: the influence of relative localisation of radical generation, antioxidants, and target proteins. Free Radical Biology and Medicine 1991; 11: 161–168
   PubMed Web of Science ®Google Scholar
• Dean R. T., Thomas S. M., Garner A. C. Free-Radical-mediated fragmentation of monoamine oxidase in the mitochondrial membrane. Roles for lipid radicals. Biochemical Journal 1986; 240: 489–494
   PubMed Web of Science ®Google Scholar
• Thomas S. M., Gebicki J. M., Dean R. T. Radical-initiated α-tocopherol depletion and lipid peroxidation in mitochondrial membranes. Biochimica Biophysica Acta 1989; 1002: 189–197
   PubMed Web of Science ®Google Scholar
• Gutteridge J. M.C. Ferrous-salt-promoted damage to deoxyribose and benzoate. Biochemical Journal 1987; 243: 709–714
   PubMed Web of Science ®Google Scholar
• Singh S., Hider R. C. Colorimetric detection of the hydroxyl radical: comparison of the hydroxyl-radical-generating ability of various iron complexes. Analytical Biochemistry 1988; 171: 47–54
   PubMed Web of Science ®Google Scholar
• Maskos Z., Rush J. D., Koppenol W. H. The hydroxylation of phenylalanine and tyrosine: a comparison with salicylate and tryptophan. Archives of Biochemistry and Biophysics 1992; 262: 521–529
   Google Scholar
• Smith J. B., Cusumano J. C., Babbs C. F. Quantitative effects of iron chelators on hydroxyl radical production by the superoxide driven Fenton reaction. Free Radical Research Communications 1990; 8: 101–106
   PubMed Web of Science ®Google Scholar
• Chevion M. A site-specific mechanism for free radical induced biological damage: The essential role of redox-active transition metals. Free Radical Biology and Medicine 1988; 5: 27–37
   PubMed Web of Science ®Google Scholar
• Rana T. M., Meares C. F. Transfer of oxygen from an artificial protease to peptide carbon during proteolysis. Proceedings of the National Academy of Sciences USA 1991; 88: 10578–10582
   PubMedGoogle Scholar
• Braughler J. M., Burton P. S., Chase R. L., Pregenzer J. F., Jacobsen E. J., Van F. J., Doornik T. J.M., Ayer D. E., Bundy G. L. Novel membrane localised iron chelators as inhibitors of iron-dependent lipid peroxidation. Biochemical Pharmacology 1988; 37: 3853–3860
   PubMedGoogle Scholar
• Burkitt M. K., Gilbert B. C. The autoxidation of various iron(II) in aqueous systems: the effects of iron chelation by physiological, non-physiological and therapeutic chelators on the generation of reactive oxygen species and the inducement of biomolecular damage. Free Radical Research Communications 1991; 14: 107–123
   PubMed Web of Science ®Google Scholar
• Iwahashi H., Morishita H., Ishii T., Sugata R., Kido R. Enhancement by catechols of hydroxyl-radical formation in the presence of ferric irons and hydrogen peroxide. Journal of Biochemistry 1989; 105: 429–434
   PubMed Web of Science ®Google Scholar
• Hershko C. Biological models for studying iron chelating drugs. Baillieres Clinical Haematology 1989; 2: 293–321
   PubMedGoogle Scholar
• Hewitt S. D., Hider R. C., Sarpong P., Morris C. J., Blake D. R. Investigation of the antiinflammatory properties of hydroxypyridinones. Annals of the Rheumatic Diseases 1989; 48: 382–388
   PubMed Web of Science ®Google Scholar
• Jin Y., Baquet A., Florence A., Crichton R. R., Schneider Y. J. Desferrithiocin and desfer-rioxamine B. Cellular pharmacology and storage iron mobilisation. Biochemical Pharmacology 1989; 38: 3233–3240
   PubMedGoogle Scholar
• Lovering K. E., Dean R. T. Restriction of the participation of copper in radical-generating systems by zinc. Free Radical Research Communications 1991; 14: 217–225
   PubMed Web of Science ®Google Scholar